Lamotrigine add-on for drug-resistant partial epilepsy. (Q30887389)

27 June 2017

1 reference

title

Lamotrigine add-on for drug-resistant partial epilepsy. (English)

1 reference

27 June 2017

Lamotrigine add-on for drug-resistant partial epilepsy (English)

0 references

1 reference

S Ramaratnam

1

1 reference

27 June 2017

A G Marson

series ordinal

2

1 reference

27 June 2017

G A Baker

series ordinal

3

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

27 June 2017

2001

0 references

published in

1 reference

27 June 2017

issue

3

1 reference

27 June 2017

page(s)

CD001909

1 reference

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Lamotrigine extended-release as adjunctive therapy for partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Vigabatrin and lamotrigine in refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Remission of epilepsy: results from the National General Practice Study of Epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

New antiepileptic drugs: a systematic review of their efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Epidemiology of the epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Controlled trial of lamotrigine (Lamictal) for refractory partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Outcomes of add-on treatment with lamotrigine in partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

The new antiepileptic drugs: a systematic review of their efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001909

10.1002/14651858.CD001909

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference